Literature DB >> 6156900

Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.

J H Laragh, D B Case, S A Atlas, J E Sealey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156900     DOI: 10.1161/01.hyp.2.4.586

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  15 in total

1.  The description and prediction of antihypertensive drug response: an individualised approach.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

2.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

3.  Angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Authors:  C I Johnston; L Arnolda; M Hiwatari
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

4.  Effect of captopril on renin and blood pressure in cirrhosis.

Authors:  B Stanek; F Renner; A Sedlmayer; K Silberbauer
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

6.  Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.

Authors:  K O Stumpe; A Overlack; R Kolloch; J Schatz; P U Witte; K Pahnke
Journal:  Klin Wochenschr       Date:  1986-06-16

Review 7.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

8.  Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.

Authors:  C I Johnston; B J Jackson; I Larmour; R Cubella; D Casley
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 10.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.